MedPath

Individualized tacrolimus therapy for ulcerative colitis based on CYP3A5 SNPs

Not Applicable
Conditions
ulcerative colitis
Registration Number
JPRN-UMIN000013694
Lead Sponsor
Kitasato University Kitasato Institute Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1. women who are pregnant, breastfeeding, or possible to be pregnant 2. individuals who are considered ineligible by the investigator

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
efficacy on day 7
Secondary Outcome Measures
NameTimeMethod
blood concentration on day 3 time to reach the target concentration (10ng/ml)
© Copyright 2025. All Rights Reserved by MedPath